机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[2]China National Clinical Research Center for Neurological Diseases, Beijing, China[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China[5]Dean’s Office, Dell Medical School, University of Texas at Austin, Austin, TX, USA[6]Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK[7]Clinical Innovation and Research Institute, Memorial Hermann Hospital, Houston, TX, USA[8]Department of Neurology and Stroke Center, Bichat University Hospital and Paris-Diderot, Sorbonne University, Paris, France[9]Department of Clinical Pharmacology and Clinical Research Platform of East of Paris, Assistance Publique-H?pitaux de Paris, Paris, France[10]Department of Clinical Pharmacology, Sorbonne Université, Paris, France[11]French Alliance for Cardiovascular Clinical Trials, Paris, France[12]Department of Neurology, University of Ulsan, Asan Medical Center, Seoul, South Korea[13]Department of Neurology and Stroke Center, National Taiwan University Hospital, Taipei, Taiwan[14]Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China[15]Division of Neurology, Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China[16]Illinois Neurological Institute Stroke Network, OSF Healthcare System, Peoria, IL, USA[17]Department of Neurology, University of Illinois College of Medicine at Peoria, Peoria, IL, USA
Ministry of Science and Technology of the People's Republic of ChinaMinistry of Science and Technology, China [2016YFC0901001, 2016YFC0901002, 2017YFC1310901, 2018YFC1311700, 2018YFC1311706]; Beijing Municipal Commission of Health and Family Planning [2016-1-2041, SML20150502]
第一作者机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[2]China National Clinical Research Center for Neurological Diseases, Beijing, China[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
通讯作者:
通讯机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[2]China National Clinical Research Center for Neurological Diseases, Beijing, China[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
推荐引用方式(GB/T 7714):
Yongjun Wang,S Claiborne Johnston,Philip M Bath,et al.Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack[J].BMJ-BRITISH MEDICAL JOURNAL.2019,364:-.doi:10.1136/bmj.l895.
APA:
Yongjun Wang,S Claiborne Johnston,Philip M Bath,James C Grotta,Yuesong Pan...&Hao Li.(2019).Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.BMJ-BRITISH MEDICAL JOURNAL,364,
MLA:
Yongjun Wang,et al."Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack".BMJ-BRITISH MEDICAL JOURNAL 364.(2019):-